Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Protease inhibitors for HCV infection developed at Vertex

Oct. 26, 1999

Potassium channel activator SKP-450 has potent antiulcer effects in rat models

Oct. 25, 1999

Canadian approval sought for new anti-HBV product

Oct. 22, 1999

AstraZeneca files first application for improved PPI

Oct. 22, 1999

Rebetol combination therapy launched in Italy for treatment of chronic HCV

Oct. 19, 1999

Lotronex NDA up for review next month by GI advisory committee

Oct. 18, 1999

New treatment for GERD now available in U.S.

Oct. 18, 1999

Alpha-glucosidase inhibition as a target for development of broad-based anti-hepatitis virus agents

Oct. 18, 1999

Patent application filed covering new use of CBP-1011 for IBD

Oct. 15, 1999

Licensing opportunity from NIH: novel integrin antagonists for treating inflammatory disease

Oct. 12, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...